Home » Healthcare » Onychomycosis Treatment Market

Onychomycosis Treatment Market By Disease Type (Distal Subungual Onychomycosis, Proximal Subungual Onychomycosis, White Superficial Onychomycosis, Candidal Onychomycosis, Others) By Treatment Type (Laser Therapy, Photodynamic Therapy, Drug Treatment) By Drug Class (Allylamine, Azole, Griseofulvin,Others) By Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, Others) – Growth, Future Prospects & Competitive Analysis, 2016 – 2028

Summary
Table Of Content

About this report

The Global Onychomycosis Treatment Market report explores the critical analysis of the onychomycosis treatment industry using key parameters. The report consists of investment strategies, the need for investments in the onychomycosis treatment industry, and the multiple benefits for the investors. Importantly, this report sets out major changes in the global technical regulations for the onychomycosis treatment industry and how economic and non-economic barriers are helping the market grow. Moreover, the report analyses the global, regional, and country-level historic and forecasted market size. The report also provides a comprehensive analysis of key investment propositions, demand and supply gap, competitors positioning, STAR analysis, SRC analysis, and Tornado analysis. Key technological developments and other analyses include Porter’s five forces analysis, PESTEL analysis, value chain analysis, etc.

Key Highlights of the report

How are the major segments performing in the Onychomycosis Treatment Market?

The distal subungual onychomycosis segment led the market in disease type in 2021 and is expected to continue throughout the projection period. The segment is growing due to increased hospital adoption of laser technologies for treating distal subungual onychomycosis and growing patient awareness about the availability of various therapies for distal subungual onychomycosis. The increased R&D activities to develop advanced products for treating distal subungual onychomycosis nail infection propels the onychomycosis treatment market forward.
The drug treatment type segment led the global market in 2021 due to increasing drug adoption as first-line therapy for the treatment of fungal infection diseases in the nails and a rising number of product launches. The increased investment by major players in developing high-quality drugs for skin conditions in the nails is propelling the onychomycosis treatment market forward.
In 2021, the allylamine segment held the largest share of the drug class. Allylamines are the most widely used drug class and are effective against most fungal infections. Topical allylamines such as Lamisil and Naftin are used to treat onychomycosis. The increased availability and use of such drugs will impact industry revenue over the forecast period.
In 2021, the hospitals and clinics segment dominated the global market in distribution channels due to increased hospital and clinic visits and the availability of drugs in hospital pharmacies. Also, market revenue generated through hospital and clinic pharmacies is higher as infected patients visit nearby hospitals for doctors’ and consultation prescriptions.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Which region dominated the Onychomycosis Treatment Market?

North America dominated the onychomycosis treatment market in 2021 and is expected to maintain its dominance throughout the forecast period. This can be attributed to an increase in nail-borne infections, diabetes, and increased awareness of available treatments. Another key factor influencing regional growth is the accessibility of highly effective treatment options for onychomycosis, such as prescription drugs and laser therapies. The landscape of North America benefits greatly from a favorable reimbursement environment in the U.S. and the highest onychomycosis prevalence. The region’s market will benefit from increased R&D activities. For instance, Pfizer Inc. announced the start of its onychomycosis clinical studies in October 2020. The first phase involved determining whether the AN2690 topical solution is an effective treatment for toenail onychomycosis.

What is the competitive environment of the Onychomycosis Treatment Market?

There are numerous players in the onychomycosis treatment market. Manufacturers in the market invest heavily in research and development. These are the activities that support the onychomycosis treatment market. They result in the development of new formulations and treatment options. Mergers, partnerships, and collaborations are always top priorities for onychomycosis treatment market players. These activities help increase the players’ influence, eventually leading to an increase in the growth rate. For instance, Alembic Pharmaceuticals Limited (Alembic) announced in April 2021 that its joint venture Aleor Dermaceuticals Ltd had received tentative approval from the US Food & Drug Administration for its abbreviated new drug application (ANDA) for Efinaconazole Topical Solution for the treatment of toenail onychomycosis. Likewise, Moberg Pharma announced a partnership with Bayer in February 2019 to promote and distribute MOB-015 in Europe. MOB-015 is an internally developed topical formulation for the treatment of onychomycosis.

Executive Summary

What are all the technical developments being developed in the Onychomycosis Treatment Market?

The increased adoption of laser technologies for treating distal subungual onychomycosis in hospitals, the rising adoption of drug treatments, and growing investment by major players to develop high-quality onychomycosis therapies are expected to drive market growth. Laser onychomycosis treatment is a painless and non-invasive method of targeting the fungus that causes onychomycosis. The laser light penetrates the nail and kills the fungus while causing no harm to the surrounding tissue. Laser treatment for onychomycosis is a safe and effective alternative to oral antifungal medications, which can have side effects. For instance, the next-generation nail fungus treatment MOB-015 (Moberg Pharma) is aimed at the global over-the-counter (OTC) and prescription markets. The company’s patented formulation technology allows high concentrations of a proven antifungal substance (terbinafine) to be delivered into and through the nail. It has keratolytic and emollient properties that contribute to visible improvement in a short period.

Which are the key investments by the players in the Onychomycosis Treatment Market?

Pharmaceutical companies have increased their R&D spending on the disease due to its rising prevalence. Various topical treatment solutions fail to penetrate deep inside the nail bed and thus do not completely cure the infection. Various players are investing heavily in developing novel drugs to meet the growing demand for cures. For instance, Hexima conducts a phase I/II clinical study on HXP124, a plant defensin anti-fungal molecule for treating dermatophytes onychomycosis. HXP124 has a higher penetration rate than Kerydin and Jublia. Similarly, Hallux, a US-based player, completed a USD 7.1 million Series A round in December 2020, allowing it to conduct Phase IIa clinical trials of its drug/device combination product for onychomycosis.

Some of the major players in the market are Cipla Limited, Bausch Health Companies Inc, Dr. Reddy’s Laboratories, GlaxoSmithKline PLC, Galderma SA, Kaken Pharmaceutical Co. Ltd, Moberg Pharma AB, Lumenis Ltd, Novartis AG, Pfizer Inc, and The OTC Lab B.V.

What are the Major Driving Factors for the Onychomycosis Treatment Market?

One of the key factors driving the market growth is the rising prevalence of chronic medical conditions such as onychomycosis, diabetes, HIV, and peripheral artery disease (PAD). Moreover, the growing geriatric population, prone to circulatory disorders and weakened immune systems, is propelling market growth. Onychomycosis is also common among millennials and adults, owing to increased exposure to public swimming pools and the use of contaminated, tight, or soiled clothes, shoes, and socks. Another driver of market expansion is the emergence of orally administrable, water-soluble antifungal treatment methods.

What are the Major Risks for the Onychomycosis Treatment Market?

Antifungal medications used to treat onychomycosis can cause side effects like nausea, vomiting, headaches, and stomach aches. Besides that, the topical treatments also result in rash and itching of the nearby skin. These adverse effects are expected to impede the global market growth. Alternative treatment options available for nail infections, such as Vicks Vapour Listerine and tea tree oil, are also expected to hinder the market growth over the forecast period.

Which is the key Distribution Channel in the Onychomycosis Treatment Market?

The hospitals and clinics segment led the global market in the distribution channel in 2021, and this trend is expected to continue throughout the projection period. One of the major contributors to this revenue share is the high prevalence of onychomycosis patients visiting dermatology hospitals and clinics. Besides, rising awareness about early clinical diagnosis and treatment of onychomycosis is expected to drive segment growth over the forecast period. Infected patients visit nearby hospitals for doctor visits and prescriptions, which results in higher industry revenue for hospital and clinic pharmacies.

How is the Onychomycosis Treatment Market performing in regions?

North America dominated the global market for onychomycosis treatment in 2021, owing to high drugs cost, a growing geriatric population, and a rising prevalence of diabetic and onychomycosis patient populations in the region. More than 55 million Americans are 65 years of age or older, and one-fourth of them reside in one of the three states of Florida, California, or Texas, according to Census Bureau projections for the year 2020. Seven other states, including Michigan, Illinois, Georgia, and New York, account for nearly another quarter of the 65+ population. Onychomycosis is more common as people age for various reasons, including frequent nail trauma, poor peripheral circulation, diabetes, subpar immune function, prolonged exposure to pathogenic fungi, inactivity, or the inability to trim toenails or maintain proper foot hygiene. Regional companies also strengthen their market position through various strategies such as R&D, mergers and acquisitions, and new drug launches.

Besides, Asia Pacific is expected to grow the most during the forecast period due to the increased adoption of antifungal agents for treating white superficial onychomycosis and increased investment by key players in developing high-quality onychomycosis treatment methods. For example, Kaken Pharmaceuticals Co. Ltd announced the launch of Jublia as a treatment method for dermatophytes onychomycosis in Hong Kong in 2020. Moreover, increasing the number of patients seeking medical advice due to increased awareness about various treatment options will increase regional demand.

What is the regulatory landscape for the Onychomycosis Treatment Market?

Governments worldwide are also working to raise awareness about the availability of various therapies for treating onychomycosis, fueling the global market growth. For instance, patient information leaflets for nail fungus infections are available from the British Association of Dermatologists. Increasing regulatory approval is also another key factor contributing to market growth. For instance, Zydus Lifesciences received approval from the US Food and Drug Administration in 2022 to market the antifungal Efinaconazole Topical Solution. The company has received final FDA approval to market the product. Also, Lupin Ltd received US Food and Drug Administration approval for its Tavaborole Topical Solution for onychomycosis in February 2021.

What is the Market Size of the Onychomycosis Treatment Market regarding value?

The global onychomycosis treatment market is anticipated to grow at a substantial CAGR of 5.3% in the upcoming years. The global onychomycosis treatment industry was estimated to be worth USD 4372.5 million in 2021 and was expected to be worth USD 5960.73 million by 2028.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

What are the major players planning for the future of the Onychomycosis Treatment Market?

Identifying the infectious agent in onychomycosis, at least at the genus level, is critical in treating dermatophytes onychomycosis. Key market players are concentrating on developing dermatophyte strip tests to diagnose the disease rapidly. The rising cases of liver damage in patients will lead to high demand for future market growth. The development of oral anti-fungal drugs and topical treatment solutions associated with liver damage will allow the market to expand rapidly. The growing demand for better topical solutions will drive podiatrists and dermatologists to present new drug enhancement theories, which will bode well for the market. Besides, the growing popularity of nail lacquers will open up new market opportunities during the forecast period. Moreover, rising R&D spending by major players will significantly impact the market.

Segmentation of Global Onychomycosis Treatment Market –

Global Onychomycosis Treatment Market – By Disease Type

Distal Subungual Onychomycosis
Proximal Subungual Onychomycosis
White Superficial Onychomycosis
Candidal Onychomycosis
Others

Global Onychomycosis Treatment Market – By Treatment Type

Laser Therapy
Photodynamic Therapy
Drug Treatment

Global Onychomycosis Treatment Market – By Drug Class

Allylamine
Azole
Griseofulvin
Others

Global Onychomycosis Treatment Market – By Distribution Channel

Hospitals and Clinics
Online Stores
Retail Pharmacies
Others

Global Onychomycosis Treatment Market – By Region

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation

2. Executive Summary
2.1. Market Snapshot: Global Onychomycosis Treatment Market
2.2. Global Onychomycosis Treatment Market, By Disease Type
2.3. Global Onychomycosis Treatment Market, By Treatment Type
2.4. Global Onychomycosis Treatment Market, By Drug Class
2.5. Global Onychomycosis Treatment Market, By Distribution Channel
2.6. Global Onychomycosis Treatment Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Onychomycosis Treatment Market Value, 2016-2028, (US$ Bn)
3.2. Market Dynamics
3.2.1. Key Growth Trends
3.2.2. Market Drivers
3.2.3. Market Restraints
3.2.4. Market Opportunities
3.2.5. Major Industry Challenges
3.3. Attractive Investment Proposition,2021
3.3.1. Disease Type
3.3.2. Treatment Type
3.3.3. Drug Class
3.3.4. Distribution Channel
3.3.5. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Value Chain Analysis
4.4. Technology Analysis
4.5. Marketing Strategy Analysis
4.5.1. Direct Marketing
4.5.2. Indirect Marketing
4.5.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2021
5.1. Company market share of key players, 2021
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. COVID-19 Impact Analysis
6.1. Global Onychomycosis Treatment Market Pre Vs Post COVID 19, 2019 – 2028
6.2. Impact on Import & Export
6.3. Impact on Demand & Supply

7. Global Onychomycosis Treatment Market
7.1. Global Onychomycosis Treatment Market, by Disease Type, 2016-2028(US$ Bn)
7.1.1. Overview
7.1.2. Global Onychomycosis Treatment Market, By Disease Type, 2021 vs 2028 (in%)
7.1.3. Global Onychomycosis Treatment Market, By Distal Subungual Onychomycosis, 2016-2028 (US$ Bn)
7.1.4. Global Onychomycosis Treatment Market, By Proximal Subungual Onychomycosis, 2016-2028 (US$ Bn)
7.1.5. Global Onychomycosis Treatment Market, By White Superficial Onychomycosis, 2016-2028 (US$ Bn)
7.1.6. Global Onychomycosis Treatment Market, By Candidal Onychomycosis, 2016-2028 (US$ Bn)
7.1.7. Global Onychomycosis Treatment Market, By Others, 2016-2028 (US$ Bn)
7.2. Global Onychomycosis Treatment Market, by Treatment Type, 2016-2028(US$ Bn)
7.2.1. Overview
7.2.2. Global Onychomycosis Treatment Market, By Treatment Type, 2021 vs 2028 (in%)
7.2.3. Global Onychomycosis Treatment Market, By Laser Therapy, 2016-2028 (US$ Bn)
7.2.4. Global Onychomycosis Treatment Market, By Photodynamic Therapy, 2016-2028 (US$ Bn)
7.2.5. Global Onychomycosis Treatment Market, By Drug Treatment, 2016-2028 (US$ Bn)
7.3. Global Onychomycosis Treatment Market, by Drug Class, 2016-2028(US$ Bn)
7.3.1. Overview
7.3.2. Global Onychomycosis Treatment Market, By Drug Class, 2021 vs 2028 (in%)
7.3.3. Global Onychomycosis Treatment Market, By Allylamine, 2016-2028 (US$ Bn)
7.3.4. Global Onychomycosis Treatment Market, By Azole, 2016-2028 (US$ Bn)
7.3.5. Global Onychomycosis Treatment Market, By Griseofulvin, 2016-2028 (US$ Bn)
7.3.6. Global Onychomycosis Treatment Market, By Others, 2016-2028 (US$ Bn)
7.4. Global Onychomycosis Treatment Market, by Distribution Channel, 2016-2028(US$ Bn)
7.4.1. Overview
7.4.2. Global Onychomycosis Treatment Market, By Distribution Channel, 2021 vs 2028 (in%)
7.4.3. Global Onychomycosis Treatment Market, By Hospitals and Clinics, 2016-2028 (US$ Bn)
7.4.4. Global Onychomycosis Treatment Market, By Online Stores, 2016-2028 (US$ Bn)
7.4.5. Global Onychomycosis Treatment Market, By Retail Pharmacies, 2016-2028 (US$ Bn)
7.4.6. Global Onychomycosis Treatment Market, By Others, 2016-2028 (US$ Bn)

8. North America Onychomycosis Treatment Market Analysis
8.1. North America Onychomycosis Treatment Market, by Disease Type, 2016-2028(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Onychomycosis Treatment Market, by Treatment Type, 2016-2028(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Onychomycosis Treatment Market, by Drug Class, 2016-2028(US$ Bn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America Onychomycosis Treatment Market, by Distribution Channel, 2016-2028(US$ Bn)
8.4.1. Overview
8.4.2. SRC Analysis
8.5. North America Onychomycosis Treatment Market, by Country, 2016-2028 (US$ Bn)
8.5.1. U.S.
8.5.1.1. U.S. Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.5.1.2. U.S. Onychomycosis Treatment Market, By Disease Type, 2016-2028 (US$ Bn)
8.5.1.3. U.S. Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
8.5.1.4. U.S. Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
8.5.1.5. U.S. Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)
8.5.2. Canada
8.5.2.1. Canada Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.5.2.2. Canada Onychomycosis Treatment Markets, By Disease Type, 2016-2028 (US$ Bn)
8.5.2.3. Canada Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
8.5.2.4. Canada Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
8.5.2.5. Canada Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)

9. Europe Onychomycosis Treatment Market Analysis
9.1. Europe Onychomycosis Treatment Market, by Disease Type, 2016-2028(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Onychomycosis Treatment Market, by Treatment Type, 2016-2028(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Onychomycosis Treatment Market, by Drug Class, 2016-2028(US$ Bn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe Onychomycosis Treatment Market, by Distribution Channel, 2016-2028(US$ Bn)
9.4.1. Overview
9.4.2. SRC Analysis
9.5. Europe Onychomycosis Treatment Market, by Country, 2016-2028 (US$ Bn)
9.5.1. Germany
9.5.1.1. Germany Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.5.1.2. Germany Onychomycosis Treatment Market, By Disease Type, 2016-2028 (US$ Bn)
9.5.1.3. Germany Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
9.5.1.4. Germany Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
9.5.1.5. Germany Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)
9.5.2. France
9.5.2.1. France Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.5.2.2. France Onychomycosis Treatment Market, By Disease Type, 2016-2028 (US$ Bn)
9.5.2.3. France Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
9.5.2.4. France Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
9.5.2.5. France Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)
9.5.3. UK
9.5.3.1. UK Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.5.3.2. UK Onychomycosis Treatment Market, By Disease Type, 2016-2028 (US$ Bn)
9.5.3.3. UK Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
9.5.3.4. UK Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
9.5.3.5. UK Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)
9.5.4. Italy
9.5.4.1. Italy Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.5.4.2. Italy Onychomycosis Treatment Market, By Disease Type, 2016-2028 (US$ Bn)
9.5.4.3. Italy Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
9.5.4.4. Italy Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
9.5.4.5. Italy Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)
9.5.5. Spain
9.5.5.1. Spain Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.5.5.2. Spain Onychomycosis Treatment Market, By Disease Type, 2016-2028 (US$ Bn)
9.5.5.3. Spain Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
9.5.5.4. Spain Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
9.5.5.5. Spain Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)
9.5.6. Rest of Europe
9.5.6.1. Rest of Europe Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.5.6.2. Rest of Europe Onychomycosis Treatment Market, By Disease Type, 2016-2028 (US$ Bn)
9.5.6.3. Rest of Europe Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
9.5.6.4. Rest of Europe Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
9.5.6.5. Rest of Europe Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)

10. Asia Pacific Onychomycosis Treatment Market Analysis
10.1. Asia Pacific Onychomycosis Treatment Market, by Disease Type, 2016-2028(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Onychomycosis Treatment Market, by Treatment Type, 2016-2028(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Onychomycosis Treatment Market, by Drug Class, 2016-2028(US$ Bn)
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific Onychomycosis Treatment Market, by Distribution Channel, 2016-2028(US$ Bn)
10.4.1. Overview
10.4.2. SRC Analysis
10.5. Asia Pacific Onychomycosis Treatment Market, by Country, 2016-2028 (US$ Bn)
10.5.1. China
10.5.1.1. China Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.5.1.2. China Onychomycosis Treatment Market, By Disease Type, 2016-2028 (US$ Bn)
10.5.1.3. China Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
10.5.1.4. China Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
10.5.1.5. China Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)
10.5.2. Japan
10.5.2.1. Japan Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.5.2.2. Japan Onychomycosis Treatment Market, By Disease Type, 2016-2028 (US$ Bn)
10.5.2.3. Japan Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
10.5.2.4. Japan Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
10.5.2.5. Japan Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)
10.5.3. India
10.5.3.1. India Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.5.3.2. India Onychomycosis Treatment Market, By Disease Type, 2016-2028 (US$ Bn)
10.5.3.3. India Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
10.5.3.4. India Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
10.5.3.5. India Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)
10.5.4. South Korea
10.5.4.1. South Korea Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.5.4.2. South Korea Onychomycosis Treatment Market, By Disease Type, 2016-2028 (US$ Bn)
10.5.4.3. South Korea Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
10.5.4.4. South Korea Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
10.5.4.5. South Korea Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)
10.5.5. South-East Asia
10.5.5.1. South-East Asia Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.5.5.2. South-East Asia Onychomycosis Treatment Market, By Disease Type, 2016-2028 (US$ Bn)
10.5.5.3. South-East Asia Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
10.5.5.4. South-East Asia Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
10.5.5.5. South-East Asia Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)
10.5.6. Rest of Asia Pacific
10.5.6.1. Rest of Asia Pacific Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.5.6.2. Rest of Asia Pacific Onychomycosis Treatment Market, By Disease Type, 2016-2028 (US$ Bn)
10.5.6.3. Rest of Asia Pacific Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
10.5.6.4. Rest of Asia Pacific Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
10.5.6.5. Rest of Asia Pacific Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)

11. Latin America Onychomycosis Treatment Market Analysis
11.1. Latin America Onychomycosis Treatment Market, by Disease Type, 2016-2028(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Onychomycosis Treatment Market, by Treatment Type, 2016-2028(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Onychomycosis Treatment Market, by Drug Class, 2016-2028(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America Onychomycosis Treatment Market, by Distribution Channel, 2016-2028(US$ Bn)
11.4.1. Overview
11.4.2. SRC Analysis
11.5. Latin America Onychomycosis Treatment Market, by Country, 2016-2028 (US$ Bn)
11.5.1. Brazil
11.5.1.1. Brazil Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.5.1.2. Brazil Onychomycosis Treatment Market, By Disease Type, 2016-2028 (US$ Bn)
11.5.1.3. Brazil Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
11.5.1.4. Brazil Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
11.5.1.5. Brazil Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)
11.5.2. Mexico
11.5.2.1. Mexico Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.5.2.2. Mexico Onychomycosis Treatment Market, By Disease Type, 2016-2028 (US$ Bn)
11.5.2.3. Mexico Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
11.5.2.4. Mexico Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
11.5.2.5. Mexico Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)
11.5.3. Rest of Latin America
11.5.3.1. Rest of Latin America Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.5.3.2. Rest of Latin America Onychomycosis Treatment Market, By Disease Type, 2016-2028 (US$ Bn)
11.5.3.3. Rest of Latin America Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
11.5.3.4. Rest of Latin America Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
11.5.3.5. Rest of Latin America Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)

12. Middle East and Africa Onychomycosis Treatment Market Analysis
12.1. Middle East and Africa Onychomycosis Treatment Market, by Disease Type, 2016-2028(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Onychomycosis Treatment Market, by Treatment Type, 2016-2028(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Onychomycosis Treatment Market, by Drug Class, 2016-2028(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa Onychomycosis Treatment Market, by Distribution Channel, 2016-2028(US$ Bn)
12.4.1. Overview
12.4.2. SRC Analysis
12.5. Middle East and Africa Onychomycosis Treatment Market, by Country, 2016-2028 (US$ Bn)
12.5.1. GCC Countries
12.5.1.1. GCC Countries Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.5.1.2. GCC Countries Onychomycosis Treatment Market, By Disease Type, 2016-2028 (US$ Bn)
12.5.1.3. GCC Countries Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
12.5.1.4. GCC Countries Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
12.5.1.5. GCC Countries Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)
12.5.2. South Africa
12.5.2.1. South Africa Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.5.2.2. South Africa Onychomycosis Treatment Market, By Disease Type, 2016-2028 (US$ Bn)
12.5.2.3. South Africa Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
12.5.2.4. South Africa Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
12.5.2.5. South Africa Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)
12.5.3. Rest of Middle East and Africa
12.5.3.1. Rest of Middle East and Africa Onychomycosis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.5.3.2. Rest of Middle East and Africa Onychomycosis Treatment Market, By Disease Type, 2016-2028 (US$ Bn)
12.5.3.3. Rest of Middle East and Africa Onychomycosis Treatment Market, By Treatment Type, 2016-2028 (US$ Bn)
12.5.3.4. Rest of Middle East and Africa Onychomycosis Treatment Market, By Drug Class, 2016-2028 (US$ Bn)
12.5.3.5. Rest of Middle East and Africa Onychomycosis Treatment Market, By Distribution Channel, 2016-2028 (US$ Bn)

13. Company Profiles
13.1. Cipla Limited
13.1.1. Company Overview
13.1.2. Products/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2021)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Bausch Health Companies Inc
13.3. Dr. Reddy’s Laboratories
13.4. GlaxoSmithKline PLC
13.5. Galderma SA
13.6. Kaken Pharmaceutical Co. Ltd
13.7. Moberg Pharma AB
13.8. Lumenis Ltd
13.9. Novartis AG
13.10. Pfizer Inc
13.11. The OTC Lab B.V.

List of Figures

FIG. 1 Global Onychomycosis Treatment Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Onychomycosis Treatment Market Segmentation
FIG. 4 Global Onychomycosis Treatment Market, by Disease Type, 2021 (US$ Bn)
FIG. 5 Global Onychomycosis Treatment Market, by Treatment Type, 2021 (US$ Bn)
FIG. 6 Global Onychomycosis Treatment Market, by Drug Class, 2021 (US$ Bn)
FIG. 7 Global Onychomycosis Treatment Market, by Distribution Channel, 2021 (US$ Bn)
FIG. 8 Global Onychomycosis Treatment Market, by Geography, 2021 (US$ Bn)
FIG. 9 Attractive Investment Proposition, by Disease Type, 2021
FIG. 10 Attractive Investment Proposition, by Treatment Type, 2021
FIG. 11 Attractive Investment Proposition, by Drug Class, 2021
FIG. 12 Attractive Investment Proposition, by Distribution Channel, 2021
FIG. 13 Attractive Investment Proposition, by Geography, 2021
FIG. 14 Global Market Share Analysis of Key Onychomycosis Treatment Market Manufacturers, 2021
FIG. 15 Global Market Positioning of Key Onychomycosis Treatment Market Manufacturers, 2021
FIG. 16 Global Onychomycosis Treatment Market Value Contribution, By Disease Type, 2021 & 2028 (Value %)
FIG. 17 Global Onychomycosis Treatment Market, by Distal Subungual Onychomycosis, Value, 2016-2028 (US$ Bn)
FIG. 18 Global Onychomycosis Treatment Market, by Proximal Subungual Onychomycosis, Value, 2016-2028 (US$ Bn)
FIG. 19 Global Onychomycosis Treatment Market, by White Superficial Onychomycosis, Value, 2016-2028 (US$ Bn)
FIG. 20 Global Onychomycosis Treatment Market, by Candidal Onychomycosis, Value, 2016-2028 (US$ Bn)
FIG. 21 Global Onychomycosis Treatment Market, by Others, Value, 2016-2028 (US$ Bn)
FIG. 22 Global Onychomycosis Treatment Market Value Contribution, By Treatment Type, 2021 & 2028 (Value %)
FIG. 23 Global Onychomycosis Treatment Market, by Laser Therapy, Value, 2016-2028 (US$ Bn)
FIG. 24 Global Onychomycosis Treatment Market, by Photodynamic Therapy, Value, 2016-2028 (US$ Bn)
FIG. 25 Global Onychomycosis Treatment Market, by Drug Treatment, Value, 2016-2028 (US$ Bn)
FIG. 26 Global Onychomycosis Treatment Market Value Contribution, By Drug Class, 2021 & 2028 (Value %)
FIG. 27 Global Onychomycosis Treatment Market, by Allylamine, Value, 2016-2028 (US$ Bn)
FIG. 28 Global Onychomycosis Treatment Market, by Azole, Value, 2016-2028 (US$ Bn)
FIG. 29 Global Onychomycosis Treatment Market, by Griseofulvin, Value, 2016-2028 (US$ Bn)
FIG. 30 Global Onychomycosis Treatment Market, by Others, Value, 2016-2028 (US$ Bn)
FIG. 31 Global Onychomycosis Treatment Market Value Contribution, By Distribution Channel, 2021 & 2028 (Value %)
FIG. 32 Global Onychomycosis Treatment Market, by Hospitals and Clinics, Value, 2016-2028 (US$ Bn)
FIG. 33 Global Onychomycosis Treatment Market, by Online Stores, Value, 2016-2028 (US$ Bn)
FIG. 34 Global Onychomycosis Treatment Market, by Retail Pharmacies, Value, 2016-2028 (US$ Bn)
FIG. 35 Global Onychomycosis Treatment Market, by Others, Value, 2016-2028 (US$ Bn)
FIG. 36 U.S. Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 37 Canada Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 38 Germany Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 39 France Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 40 U.K. Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 41 Italy Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 42 Spain Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 43 Rest of Europe Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 44 China Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 45 Japan Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 46 India Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 47 South Korea Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 48 Southeast Asia Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 49 Rest of Asia Pacific Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 50 Latin America Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 51 Brazil Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 52 Mexico Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 53 Rest of Latin America Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 54 Middle East & Africa Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 55 GCC Countries Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 56 South Africa Onychomycosis Treatment Market, 2016-2028 (US$ Bn)
FIG. 57 Rest of Middle East and Africa Onychomycosis Treatment Market, 2016-2028 (US$ Bn)

List of Tables

TABLE 1 Market Snapshot: Global Onychomycosis Treatment Market
TABLE 2 Global Onychomycosis Treatment Market, by Competitive Benchmarking, 2021
TABLE 3 Global Onychomycosis Treatment Market, by Geographical Presence Analysis, 2021
TABLE 4 Global Onychomycosis Treatment Market, by Key Strategies Analysis, 2021
TABLE 5 Global Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 6 Global Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 7 Global Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 8 Global Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 9 Global Onychomycosis Treatment Market, by Geography, 2016-2028 (US$ Bn)
TABLE 10 North America Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 11 North America Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 12 North America Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 13 North America Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 14 North America Onychomycosis Treatment Market, by Country, 2016-2028 (US$ Bn)
TABLE 15 US Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 16 US Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 17 US Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 18 US Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 19 Canada Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 20 Canada Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 21 Canada Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 22 Canada Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 23 Europe Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 24 Europe Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 25 Europe Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 26 Europe Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 27 Europe Onychomycosis Treatment Market, by Country, 2016-2028 (US$ Bn)
TABLE 28 Germany Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 29 Germany Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 30 Germany Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 31 Germany Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 32 France Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 33 France Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 34 France Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 35 France Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 36 UK Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 37 UK Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 38 UK Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 39 UK Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 40 Italy Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 41 Italy Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 42 Italy Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 43 Italy Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 44 Spain Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 45 Spain Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 46 Spain Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 47 Spain Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 48 Rest of Europe Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 49 Rest of Europe Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 50 Rest of Europe Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 51 Rest of Europe Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 52 Asia Pacific Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 53 Asia Pacific Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 54 Asia Pacific Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 55 Asia Pacific Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 56 Asia Pacific Onychomycosis Treatment Market, by Country, 2016-2028 (US$ Bn)
TABLE 57 China Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 58 China Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 59 China Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 60 China Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 61 Japan Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 62 Japan Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 63 Japan Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 64 Japan Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 65 India Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 66 India Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 67 India Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 68 India Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 69 South Korea Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 70 South Korea Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 71 South Korea Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 72 South Korea Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 73 South East Asia Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 74 South East Asia Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 75 South East Asia Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 76 South East Asia Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 77 Rest of Asia Pacific Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 78 Rest of Asia Pacific Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 79 Rest of Asia Pacific Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 80 Rest of Asia Pacific Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 81 Latin America Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 82 Latin America Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 83 Latin America Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 84 Latin America Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 85 Latin America Onychomycosis Treatment Market, by Country, 2016-2028 (US$ Bn)
TABLE 86 Brazil Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 87 Brazil Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 88 Brazil Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 89 Brazil Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 90 Mexico Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 91 Mexico Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 92 Mexico Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 93 Mexico Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 94 Rest of Latin America Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 95 Rest of Latin America Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 96 Rest of Latin America Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 97 Rest of Latin America Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 98 Middle East and Africa Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 99 Middle East and Africa Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 100 Middle East and Africa Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 101 Middle East and Africa Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 102 Middle East and Africa Onychomycosis Treatment Market, by Country, 2016-2028 (US$ Bn)
TABLE 103 GCC Countries Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 104 GCC Countries Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 105 GCC Countries Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 106 GCC Countries Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 107 South Africa Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 108 South Africa Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 109 South Africa Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 110 South Africa Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 111 Rest of Middle East and Africa Onychomycosis Treatment Market, by Disease Type, 2016-2028 (US$ Bn)
TABLE 112 Rest of Middle East and Africa Onychomycosis Treatment Market, by Treatment Type, 2016-2028 (US$ Bn)
TABLE 113 Rest of Middle East and Africa Onychomycosis Treatment Market, by Drug Class, 2016-2028 (US$ Bn)
TABLE 114 Rest of Middle East and Africa Onychomycosis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)

Frequently Asked Questions:

How has COVID-19 impacted the global onychomycosis treatment market?

The global onychomycosis treatment market moderately suffered from the COVID-19 pandemic, which resulted in a decline of over 1.6% in revenue generated in 2020.

Which is the leading market for the global onychomycosis treatment market?

North American region accounted for the highest share in the global onychomycosis treatment market regarding value and volume.

What are the key drivers for the global onychomycosis treatment market growth?

The increasing prevalence of onychomycosis among the general population and the introduction of water-soluble antifungal treatment solutions are driving growth in the global onychomycosis treatment market.

Which is the major segment in the onychomycosis treatment market by Disease Type?

The distal subungual onychomycosis segment had a major share in 2021, with more than 30% of the market revenue. Besides, the white superficial onychomycosis segment is projected to witness the fastest growth.

Which major segment in the onychomycosis treatment market by Treatment Type?

The drug treatment segment had a major share in the global market in 2021 and is projected to continue its dominance over the forecast period.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –